Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Xenetic Biosciences Net Profit Margin 2013-2025 | XBIO

Xenetic Biosciences net profit margin from 2013 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
  
Xenetic Biosciences Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $0.00B $0.00B -75.00%
2024-12-31 $0.00B $0.00B -75.00%
2024-09-30 $0.00B $0.00B -75.00%
2024-06-30 $0.00B $0.00B -100.00%
2024-03-31 $0.00B $0.00B -100.00%
2023-12-31 $0.00B $0.00B -100.00%
2023-09-30 $0.00B $0.00B -133.33%
2023-06-30 $0.00B $0.00B -200.00%
2023-03-31 $0.00B $-0.01B -600.00%
2022-12-31 $0.00B $-0.01B 0.00%
2022-09-30 $0.00B $-0.01B 0.00%
2022-06-30 $0.00B $-0.01B 0.00%
2022-03-31 $0.00B $-0.01B 0.00%
2021-12-31 $0.00B $-0.01B 0.00%
2021-09-30 $0.00B $0.00B 0.00%
2021-06-30 $0.00B $-0.01B 0.00%
2021-03-31 $0.00B $-0.01B 0.00%
2020-12-31 $0.00B $-0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.006B $0.003B
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications. Additionally, Xenetic is leveraging PolyXen(TM), its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen(TM) has demonstrated its ability to improve the half-life and other pharmacological properties of next-generation biologic drugs. The Company has an exclusive license agreement with Takeda Pharmaceuticals Co. Ltd. in the field of coagulation disorders and expects to earn royalty payments under this agreement.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.473B 30.94
Zoetis (ZTS) United States $70.873B 26.44
Takeda Pharmaceutical (TAK) Japan $48.906B 9.73
Daiichi Sankyo, - (DSNKY) Japan $43.589B 22.34
BeOne Medicines - (ONC) Cayman Islands $26.870B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.896B 0.00
Merck (MKKGY) Germany $17.128B 12.55
Summit Therapeutics (SMMT) United States $15.745B 0.00
Shionogi (SGIOY) Japan $15.040B 15.07
United Therapeutics (UTHR) United States $13.122B 11.61
Neurocrine Biosciences (NBIX) United States $12.668B 43.39
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.061B 0.00
Stevanato Group S.p.A (STVN) Italy $7.511B 45.93
Corcept Therapeutics (CORT) United States $7.350B 59.75
Madrigal Pharmaceuticals (MDGL) United States $6.665B 0.00
Ionis Pharmaceuticals (IONS) United States $6.357B 0.00
Grifols, S.A (GRFS) Spain $6.188B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.164B 0.00
Hypermarcas (HYPMY) Brazil $3.059B 20.12
Crinetics Pharmaceuticals (CRNX) United States $2.662B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.585B 9.06
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.573B 13.91
NewAmsterdam Pharma (NAMS) Netherlands $2.046B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.883B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.759B 0.00
Endo (NDOI) United States $1.585B 0.00
ARS Pharmaceuticals (SPRY) United States $1.580B 0.00
Evotec AG (EVO) Germany $1.499B 0.00
Ocular Therapeutix (OCUL) United States $1.450B 0.00
Guardian Pharmacy Services (GRDN) United States $1.354B 0.00
Harrow (HROW) United States $1.129B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.011B 20.22
Verve Therapeutics (VERV) United States $1.006B 0.00
Dyne Therapeutics (DYN) United States $0.987B 0.00
Collegium Pharmaceutical (COLL) United States $0.974B 5.25
Enliven Therapeutics (ELVN) United States $0.964B 0.00
Akebia Therapeutics (AKBA) United States $0.938B 0.00
Ardelyx (ARDX) United States $0.933B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.852B 0.00
Cronos Group (CRON) Canada $0.741B 0.00
Xeris Biopharma Holdings (XERS) United States $0.729B 0.00
Elite Pharmaceuticals (ELTP) United States $0.717B 0.00
Relay Therapeutics (RLAY) United States $0.603B 0.00
USANA Health Sciences (USNA) United States $0.594B 12.91
KalVista Pharmaceuticals (KALV) United States $0.576B 0.00
Xencor (XNCR) United States $0.574B 0.00
Bioventus (BVS) United States $0.573B 14.52
Amylyx Pharmaceuticals (AMLX) United States $0.571B 0.00
Theravance Biopharma (TBPH) United States $0.546B 0.00
Zevra Therapeutics (ZVRA) United States $0.489B 0.00
Organogenesis (ORGO) United States $0.480B 0.00
Siga Technologies (SIGA) United States $0.464B 9.69
Oruka Therapeutics (ORKA) United States $0.442B 0.00
AleAnna (ANNA) United States $0.420B 0.00
Tourmaline Bio (TRML) United States $0.407B 0.00
Savara (SVRA) United States $0.354B 0.00
Altimmune (ALT) United States $0.343B 0.00
Aquestive Therapeutics (AQST) United States $0.338B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.334B 9.04
Heron Therapeutics (HRTX) United States $0.331B 0.00
Nektar Therapeutics (NKTR) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.274B 0.00
Nature's Sunshine Products (NATR) United States $0.274B 25.17
Liminatus Pharma (LIMN) United States $0.269B 0.00
Aldeyra Therapeutics (ALDX) United States $0.235B 0.00
Nanobiotix S.A (NBTX) France $0.215B 0.00
OmniAb (OABI) United States $0.213B 0.00
MediWound (MDWD) Israel $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.198B 0.00
4D Molecular Therapeutics (FDMT) United States $0.192B 0.00
Larimar Therapeutics (LRMR) United States $0.184B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
ProKidney (PROK) United States $0.165B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Aclaris Therapeutics (ACRS) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.145B 0.00
Galectin Therapeutics (GALT) United States $0.141B 0.00
Lexeo Therapeutics (LXEO) United States $0.140B 0.00
Lyell Immunopharma (LYEL) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.139B 0.00
Korro Bio (KRRO) United States $0.120B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.114B 0.00
Cardiol Therapeutics (CRDL) Canada $0.109B 0.00
Protara Therapeutics (TARA) United States $0.108B 0.00
VAXART, INC (VXRT) United States $0.105B 0.00
Champions Oncology (CSBR) United States $0.100B 16.39
Nutriband (NTRB) United States $0.089B 0.00
Cassava Sciences (SAVA) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.088B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Fractyl Health (GUTS) United States $0.077B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Achieve Life Sciences (ACHV) Canada $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Surrozen (SRZN) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Rafael Holdings (RFL) United States $0.068B 0.00
Pyxis Oncology (PYXS) United States $0.067B 0.00
Wellgistics Health (WGRX) United States $0.065B 0.00
Inotiv (NOTV) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.062B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.057B 0.00
Context Therapeutics (CNTX) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.056B 0.00
PMV Pharmaceuticals (PMVP) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.78
Gain Therapeutics (GANX) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Telomir Pharmaceuticals (TELO) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Klotho Neurosciences (KLTO) United States $0.034B 0.00
Jupiter Neurosciences (JUNS) United States $0.033B 0.00
China SXT Pharmaceuticals (SXTC) China $0.030B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
BioVie (BIVI) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Scienture Holdings (SCNX) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.04
Cosmos Health (COSM) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.57
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00